New technologies for the detection of circulating tumour cells.

The vast majority of cancer-related death is due to the metastatic spread of the primary tumour. Circulating tumour cells (CTC) are essential for establishing metastasis and their detection has long been considered as a possible tool to assess the aggressiveness of a given tumour and its potential of subsequent growth at distant organs. Conventional markers are not reliable in detecting occult metastasis and, for example, fail to identify approximately 40% of cancer patients in need of more aggressive or better adjusted therapies. Recent studies in metastatic breast cancer have shown that CTC detection can be used as a marker for overall survival and assessment of the therapeutic response. The benefits of CTC detection in early breast cancer and other solid tumours need further validation. Moreover, optimal CTC detection techniques are the subject of controversy as several lack reproducibility, sensitivity and/or specificity. Recent technical advances allow CTC detection and characterization at the single-cell level in the blood or in the bone marrow. Their reproducibility propels the use of CTC in cancer staging and real-time monitoring of systemic anticancer therapies in several large clinical trials. CTC assays are being integrated in large clinical trials to establish their potential in the management of cancer patients and improve our understanding of metastasis biology. This review will focus on the techniques currently used, the technical advancements made, the limitations of CTC detection and future perspectives in this field.

[1]  Bjørn Naume,et al.  Circulating and disseminated tumor cells. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  C. Cordon-Cardo,et al.  Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction. , 1999, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[3]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[4]  Anne Vincent-Salomon,et al.  Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial , 2008, Clinical Cancer Research.

[5]  Brigitte Rack,et al.  Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.

[6]  H. Juhl,et al.  Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  R. Bast,et al.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Coombes,et al.  The clinical significance of disseminated tumor cells in breast cancer , 2007, Nature Clinical Practice Oncology.

[9]  L. Sobin,et al.  Classification of isolated tumor cells , 2003, Cancer.

[10]  T. Dimpfl,et al.  Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.

[11]  C. Sotiriou,et al.  Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer. , 2007, Clinical breast cancer.

[12]  Philip S Low,et al.  In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry , 2007, Proceedings of the National Academy of Sciences.

[13]  T. Fehm,et al.  A pooled analysis of bone marrow micrometastasis in breast cancer. , 2005, The New England journal of medicine.

[14]  A. Semjonow,et al.  Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene. , 2006, Cancer research.

[15]  L. Sobin,et al.  How to improve the present TNM staging system , 1999, Cancer.

[16]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[17]  Robert S. Kerbel,et al.  The multifaceted circulating endothelial cell in cancer: towards marker and target identification , 2006, Nature Reviews Cancer.

[18]  S. Burchill,et al.  The molecular detection of circulating tumour cells. , 1995, British Journal of Cancer.

[19]  Anne Vincent-Salomon,et al.  Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients , 2004, Clinical Cancer Research.

[20]  I. Fidler,et al.  Critical determinants of cancer metastasis: rationale for therapy , 1999, Cancer Chemotherapy and Pharmacology.

[21]  S. Kyo,et al.  A simple biological imaging system for detecting viable human circulating tumor cells. , 2009, The Journal of clinical investigation.

[22]  R. Kerbel,et al.  The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer. , 2009, Biochimica et biophysica acta.

[23]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[24]  S. Singletary,et al.  Revision of breast cancer staging: the 6th edition of the TNM Classification. , 2003, Seminars in surgical oncology.

[25]  K. Schütze,et al.  Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.

[26]  Nada Jabado,et al.  Circulating tumor cells: detection, molecular profiling and future prospects , 2007, Expert review of proteomics.

[27]  M. McCutcheon,et al.  Studies on the mechanisms of metastasis; the distribution of tumors in various organs in relation to the distribution of arterial emboli. , 1951, Cancer research.

[28]  Sabine Riethdorf,et al.  Circulating Tumor Cells and Bone Marrow Micrometastasis , 2008, Clinical Cancer Research.

[29]  Jamel Chelly,et al.  Illegitimate transcription: Its use in the study of inherited disease , 1992, Human mutation.

[30]  R. Eils,et al.  Systemic spread is an early step in breast cancer. , 2008, Cancer cell.

[31]  J. Rak,et al.  Vascular determinants of cancer stem cell dormancy—do age and coagulation system play a role?   , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[32]  W. Gerald,et al.  Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  L. Weiss,et al.  Observations on the Antiquity of Cancer and Metastasis , 2000, Cancer and Metastasis Reviews.

[34]  S. Shousha,et al.  Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. , 1994, Cancer research.

[35]  Stefan Sleijfer,et al.  Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. , 2009, Cancer treatment reviews.

[36]  R. Ghossein,et al.  Review: polymerase chain reaction detection of micrometastases and circulating tumor cells: application to melanoma, prostate, and thyroid carcinomas. , 1999, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[37]  Peter Kuhn,et al.  A rare-cell detector for cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Veit Zieglschmid,et al.  Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. , 2005, Anticancer research.

[39]  Ulrich Keilholz,et al.  Circulating tumor cells: the 'leukemic phase' of solid cancers. , 2006, Trends in molecular medicine.

[40]  P. Paterlini-Bréchot,et al.  Circulating tumor cells (CTC) detection: clinical impact and future directions. , 2007, Cancer letters.

[41]  Tanja Fehm,et al.  Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.

[42]  J. Nesland,et al.  Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method. , 2004, Cytotherapy.

[43]  J. Rosai,et al.  Molecular detection of micrometastases and circulating tumor cells in solid tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  L. Weiss,et al.  Metastasis of cancer: a conceptual history from antiquity to the 1990s. , 2000, Cancer metastasis reviews.

[45]  J. Köllermann,et al.  Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. Sotiriou,et al.  Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.